Merck Generics Division In Settlement Talks Over Anti-Depressant Drug Patent

Law360, New York (August 29, 2005, 12:00 AM EDT) -- New York-based Forest Laboratories Inc. and its Danish licensing partner H. Lundbeck AS are in settlement talks with Australian generic drug maker Alphapharm Pty. Ltd. over its updated antidepressant drug Lexapro, (escitalopram oxalate).

Alphapharm, part of Germany-based Merck’s generics division, was sued by Lundbeck and Forest in May 2004 in U.S. District Court for the Southern District of New York. The case was transferred in September to Delaware.

The parties announced the talks by advising the court that they have signed a term sheet and are...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.